On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Prevent Blindness

InstitutionResearch output, impact & collaborations

Prevent Blindness is a institution indexed in ScholarIQ from OpenAlex.

What is known about Prevent Blindness?

ScholarIQrecord summary

Prevent Blindness is a research organisation in Chicago, US. OpenAlex records 757 works and 54,537 citations for it. 236 researchers list it as their most recent affiliation.

How many works does Prevent Blindness have?

ScholarIQindexed works

Prevent Blindness has 757 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Prevent Blindness have?

ScholarIQcitation count

Prevent Blindness has 54,537 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Prevent Blindness?

ScholarIQresearcher count

Prevent Blindness has 236 researchers in the ScholarIQ index.

What is the average h-index at Prevent Blindness?

ScholarIQavg h-index

Prevent Blindness has an average h-index of 5.4 in OpenAlex.

What is the ROR of Prevent Blindness?

ScholarIQror

The ROR for Prevent Blindness is on the source record.

What is the OpenAlex record for Prevent Blindness?

ScholarIQopenalex

The OpenAlex for Prevent Blindness is on the source record.

Who are the most-cited researchers behind Prevent Blindness?

ScholarIQtop researchers by citations
1
Roberto González-Salinas · Intraocular Surgery and Lenses
106 works888 citations
2
Katherine Majzoub · Ophthalmology and Visual Impairment Studies
7 works47 citations
3
Anya Helfrich · Ophthalmology and Visual Impairment Studies
2 works45 citations
4
Jennifer Talbot · Ophthalmology and Visual Impairment Studies
3 works45 citations
5
Miguel Ángel Castro-Monreal · Intraocular Surgery and Lenses
7 works19 citations

What are the most-cited papers on Prevent Blindness?

ScholarIQmost cited works
Age‐Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
Luis Fernando Hernández-Zimbrón, Rubén Zamora-Alvarado, Lenin Ochoa‐de la Paz, Raúl Vélez-Montoya, Edgar Zenteno, Rosario Gulías-Cañizo, Hugo Quiroz–Mercado, Roberto González-Salinas
Oxidative Medicine and Cellular Longevity. 2018247 CitationsOPEN ACCESS
The Influence of Angle Alpha, Angle Kappa, and Optical Aberrations on Visual Outcomes after the Implantation of a High-Addition Trifocal IOL
Guadalupe Cervantes-Coste, André Tapia, Claudia Corredor-Ortega, Mariana Osorio, Rafael Valdez, Martha Massaro, Cecilio Velasco‐Barona, Roberto González-Salinas
Journal of Clinical Medicine. 202255 CitationsOPEN ACCESS
Comparison of cumulative dissipated energy delivered by active-fluidic pressure control phacoemulsification system versus gravity-fluidics
Roberto González-Salinas, Manuel Garza-León, Manuel Sáenz-de-Viteri, Juan Carlos Solís‐S, Rosario Gulías-Cañizo, Hugo Quiroz–Mercado
International Ophthalmology. 201743 Citations
Interplay between Oxidative Stress, Inflammation, and Amyloidosis in the Anterior Segment of the Eye; Its Pathological Implications
Roxanna Pérez-Garmendia, Alicia López‐de‐Eguileta, Iván Ramos-Martínez, Nayeli Martínez-Zúñiga, Roberto González-Salinas, Hugo Quiroz–Mercado, Edgar Zenteno, Eleazar Ramírez Hernández, Luis Fernando Hernández-Zimbrón
Oxidative Medicine and Cellular Longevity. 202032 CitationsOPEN ACCESS
Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial
Roberto González-Salinas, Paul Karpecki, Elizabeth Yeu, Mark Holdbrook, Stephanie N. Baba, Juan Carlos Ceballos, Martha Massaro-Corredor, Claudia Corredor-Ortega, Nallely Ramos-Betancourt, Hugo Quiroz–Mercado
Contact Lens and Anterior Eye. 202132 CitationsOPEN ACCESS

How much of the research on Prevent Blindness is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
42%
Green
0%
Hybrid
25%
Bronze
0%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial